Aardvark Therapeutics (AARD) shares debuted on Nasdaq Thursday with an opening price of $15.18, below the initial public offering price of $16.
The shares more recently were changing hands at roughly $14 apiece, further down 13%.
The stock debuted on the Nasdaq Global Market under the ticker symbol "AARD."
The IPO consists of 5.9 million shares to raise $94.2 million and the company has granted underwriters an option to buy up to an additional 883,200 shares.
Price: 13.87, Change: -2.13, Percent Change: -13.31
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。